The Tennessee Institute of Regenerative Medicine is doing cutting-edge work at the University of Tennessee Health Science Center, and their goal is to translate scientific discoveries into new therapies for people suffering from organ damage. To learn more, we talked with executive director Dr. Gabor Tigyi and UTHSC’s vice chancellor for research, Dr. Steve Goodman.
In the Media Tag: Steven Goodman
Biotechnology company Revotek, based in Chengdu, China, has long been working to 3D print blood vessels, and is now bringing its innovative technology to Memphis, Tennessee. Steven Goodman, PhD, the Vice Chancellor for research at University of Tennessee Health Science Center (UTHSC), has known Revotek’s co-founder and Chief Science Officer, Y. James Kang, PhD, a… Read More
Four research teams have just been announced as the 2017 awardees for the University of Tennessee Health Science Center (UTHSC)/ University of Arkansas for Medical Sciences (UAMS) Collaborative Research Network (CORNET) Awards in Cancer. This is the second CORNET funding opportunity established between the two institutions. The UTHSC/UAMS CORNET Awards in Cancer are designed to… Read More
You’ve heard of Botox. You’ve heard of artificial hips and knees. You’ve heard of transplants. Now you’re going to hear about living a longer time. This isn’t a story about Memphis scientists coming up with a way to live well past 80 years of age. But it’s kind of like that. Let’s say you bruise… Read More
State’s GDP relies on Chinese imports more than any other in US China Daily USA | Updated: 2017-04-20 11:05 US President Donald Trump won the state of Tennessee with 61.1 percent of the vote in the 2016 presidential election. It was the largest margin of victory for a presidential candidate from either party since 1972,… Read More